Literature DB >> 319056

Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.

M T Kelly.   

Abstract

BCG cell walls, associated with oil droplets in the form of emulsions in saline, generate macrophage chemotactic activity from fresh guinea pig plasma. Serum and heat-inactivated plasma were inactive, suggesting involvement of complement or fibrinogen-derived chemotactic factors. Suspensions of cell walls and oil droplets each generated chemotactic activity from plasma, and the activity of the cell wall vaccine was due to the additive effects of these two components. A mycobacterial glycolipid (P3), which is a constituent of BCG cell walls, also had plasma-dependent chemotactic activity. The results suggest that macrophage chemotaxis may be an important part of the immunopotentiating activity of these mycobacterial products.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319056      PMCID: PMC421346          DOI: 10.1128/iai.15.1.180-183.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.

Authors:  I Azuma; E E Ribi; T J Meyer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

Review 2.  Microparticulate gel chromatography accelerated by centrifugal force and pressure.

Authors:  E Ribi; R Parker; K Milner
Journal:  Methods Biochem Anal       Date:  1974

3.  Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.

Authors:  B Zbar; E Ribi; T Meyer; I Azuma; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

4.  Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.

Authors:  M J Snodgrass; M G Hanna
Journal:  Cancer Res       Date:  1973-04       Impact factor: 12.701

5.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

6.  Plasma-dependent chemotaxis of macrophages towards mycobacterium tuberculosis and other organisms.

Authors:  D N Symon; I C McKay; P C Wilkinson
Journal:  Immunology       Date:  1972-02       Impact factor: 7.397

7.  Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells.

Authors:  J B Hibbs
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

8.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

9.  Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets.

Authors:  D L Granger; K I Yamamoto; E Ribi
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  3 in total

1.  Antitumor activity of mycobacterial glycolipid A1.

Authors:  Z Reggiardo
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

2.  Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

Authors:  K N Masihi; W Brehmer; I Azuma; W Lange; S Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  Activation of the alternative pathway of complement by mycobacteria and cord factor.

Authors:  V D Ramanathan; J Curtis; J L Turk
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.